- ￥5264
- Cayman
- 18859-5 mg
- 2025年07月08日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Polymerase III in vitro Transcription
: 4.0 μl 5X Pol III transcription buffer 0.2 μl 0.1 M DTT 0.2 μl alpha amanatin (1 mg/ml) 0.2 μl RNAse Inhibitor H2O to a final volume of 16 microliters less the maximum volume of protein to be added. Aliquot the second mix to all reaction tubes
Oral Thrombin Inhibitor Ximelagatran
Preclinical and initial clinical experiences with the direct oral thrombin inhibitor ximelagatran demonstrated both a short and long-term potential utility for this agent in the prevention and treatment of various thromboembolic disorders
Polymerase III in vitro Transcription
except protein: 4.0 ul 5X Pol III transcription buffer 0.2 ul 0.1 M DTT 0.2 ul alpha amanatin (1 mg/ml) 0.2 ul RNAse Inhibitor H20 to a final volume of 16 microliters less the maximum volume of protein to be added. Aliquot the second mix to all reaction
技术资料暂无技术资料 索取技术资料
